//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Partnering with scientists to accelerate transformation in cancer research.
The Mark Foundation for Cancer Research
Loading...
Great feature on Drug Discovery Award winner @corsello.bsky.social by @stanforddeptmed.bsky.social! Corsello and his collaborator, Nathanael Gray, are developing novel molecular glue degraders for #pancreaticcancer. medicine.stanford.edu/news/stories...
Very happy to present my work at #EACR2026, made possible through the support of EACR- @themarkfdn.bsky.social Postdoctoral Fellowship 😊 #womeninSTEM
24d
5d
It was a pleasure to present my research at #EACR2026, supported by @helloeacr.bsky.social @themarkfdn.bsky.social postdoctoral fellowship. Thank you to all organizers & participants!
Exciting new work from Professor Chris Garcia, co-investigator on MATCHMAKERS 👏 Team MATCHMAKERS is funded through Cancer Grand Challenges by @cancerresearchuk.org, the National Cancer Institute and @themarkfdn.bsky.social
Teaching Pancreatic Cancer Cells to Self-Destruct
Q&A with Steven Corsello, MD, on a new approach to treating pancreatic cancer.
medicine.stanford.edu
The hope & joy from every oncologist & researcher in the room was palpable, and the results are a historic triumph for a disease that has resisted countless targeted therapies. But while this breakthrough is a victory for late-stage patients, we need to keep looking ahead.
The success of daraxonrasib comes through decades of dogged research to unlock a target that had been deemed “undruggable.” Now, we’re building on that momentum to help more patients sooner.